Supernus Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Abbott USD 23.15B 503M 2025-03
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Eisai JPY 727.66B 33.44B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Indivior 883M 44M 2025-03
Novo Nordisk 174.4B 20.76B 2025-03
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12



Supernus Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.